Astera Labs (NASDAQ:ALAB) Trading Down 3.6% on Insider Selling

Key Points

• Astera Labs' shares dropped by 3.6% on Friday due to insider selling, with trading volume significantly declining by 72% from its average.
• Director Jack R. Lazar sold 22,500 shares for approximately $4 million, which decreased his ownership by 18.77%.
• Equities analysts have recently set various price targets for Astera Labs, with ratings ranging from "strong buy" to "buy," and an average target price of $135.75.

Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) traded down 3.6% during trading on Friday following insider selling activity. The stock traded as low as $180.50 and last traded at $182.25. 1,386,579 shares traded hands during trading, a decline of 72% from the average session volume of 4,914,403 shares. The stock had previously closed at $189.15.

Specifically, Director Jack R. Lazar sold 22,500 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total value of $4,014,450.00. Following the transaction, the director directly owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on ALAB shares. CICC Research started coverage on shares of Astera Labs in a research report on Friday. They set an "outperform" rating and a $190.00 target price on the stock. Zacks Research raised Astera Labs to a "strong-buy" rating in a report on Tuesday, August 12th. Needham & Company LLC raised their target price on Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th. Finally, Roth Capital set a $100.00 price target on Astera Labs and gave the stock a "buy" rating in a research note on Wednesday, May 7th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $135.75.

Astera Labs Stock Performance

The company has a market cap of $30.21 billion, a PE ratio of 324.37, a PEG ratio of 4.54 and a beta of 1.39. The firm has a fifty day simple moving average of $130.65 and a 200 day simple moving average of $95.03.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. During the same quarter in the previous year, the business earned $0.13 EPS. The company's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Institutional Trading of Astera Labs

Institutional investors have recently modified their holdings of the company. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs during the 2nd quarter worth about $29,000. Bernard Wealth Management Corp. acquired a new position in Astera Labs during the 2nd quarter worth approximately $36,000. Clearstead Trust LLC lifted its position in Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company's stock worth $42,000 after acquiring an additional 461 shares in the last quarter. Advisors Asset Management Inc. lifted its position in Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock worth $43,000 after acquiring an additional 194 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its position in Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company's stock worth $44,000 after acquiring an additional 283 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.